Trump D - Search Results

1

Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.

Chadha MK, Fakih M, Muindi J, Tian L, Mashtare T, Johnson CS, Trump D. Chadha MK, et al. Among authors: trump d. Prostate. 2011 Mar 1;71(4):368-72. doi: 10.1002/pros.21250. Epub 2010 Sep 1. Prostate. 2011. PMID: 20812224 Free PMC article.

2

Phase II study of fulvestrant (Faslodex) in castration resistant prostate cancer.

Chadha MK, Ashraf U, Lawrence D, Tian L, Levine E, Silliman C, Escott P, Payne V, Trump DL. Chadha MK, et al. Among authors: trump dl. Prostate. 2008 Sep 15;68(13):1461-6. doi: 10.1002/pros.20813. Prostate. 2008. PMID: 18618738 Clinical Trial.

3

Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer.

Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, Sunga AY. Fakih MG, et al. Int J Colorectal Dis. 2009 Feb;24(2):219-24. doi: 10.1007/s00384-008-0593-y. Epub 2008 Oct 2. Int J Colorectal Dis. 2009. PMID: 18830610 Free PMC article.

4

Vitamin D deficiency and insufficiency among patients with prostate cancer.

Trump DL, Chadha MK, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W, Johnson CS. Trump DL, et al. BJU Int. 2009 Oct;104(7):909-14. doi: 10.1111/j.1464-410X.2009.08531.x. Epub 2009 Apr 4. BJU Int. 2009. PMID: 19426195 Free PMC article.

5

Serological immune responses to influenza vaccine in patients with colorectal cancer.

Puthillath A, Trump DL, Andrews C, Bir A, Romano K, Wisniewski M, Fakih MG. Puthillath A, et al. Cancer Chemother Pharmacol. 2011 Jan;67(1):111-5. doi: 10.1007/s00280-010-1292-2. Epub 2010 Mar 5. Cancer Chemother Pharmacol. 2011. PMID: 20204362

6

Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.

Lee SO, Lou W, Johnson CS, Trump DL, Gao AC. Lee SO, et al. Prostate. 2004 Aug 1;60(3):178-86. doi: 10.1002/pros.20045. Prostate. 2004. PMID: 15176047

7

Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation.

Muindi JR, Potter DM, Peng Y, Johnson CS, Trump DL. Muindi JR, et al. Cancer Chemother Pharmacol. 2005 Nov;56(5):492-6. doi: 10.1007/s00280-005-1015-2. Epub 2005 May 26. Cancer Chemother Pharmacol. 2005. PMID: 15918041 Clinical Trial.

8

Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.

Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS. Trump DL, et al. Cancer. 2006 May 15;106(10):2136-42. doi: 10.1002/cncr.21890. Cancer. 2006. PMID: 16598750 Free article. Clinical Trial.

9

Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.

Muindi JR, Peng Y, Wilson JW, Johnson CS, Branch RA, Trump DL. Muindi JR, et al. Cancer Chemother Pharmacol. 2007 Jan;59(1):97-104. doi: 10.1007/s00280-006-0247-0. Epub 2006 May 6. Cancer Chemother Pharmacol. 2007. PMID: 16680461 Clinical Trial.

10

Vitamin D compounds: clinical development as cancer therapy and prevention agents.

Trump DL, Muindi J, Fakih M, Yu WD, Johnson CS. Trump DL, et al. Anticancer Res. 2006 Jul-Aug;26(4A):2551-6. Anticancer Res. 2006. PMID: 16886663 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters